title: The role of imaging in hepatocellular carcinoma: the present and future.
abstract: Imaging plays an important role in diagnosis and management of patients with hepatocellular carcinoma (HCC). Although ultrasound is the main surveillance imaging tool for HCC, dynamic contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) are used primarily for diagnosis and staging of HCC. Recent advances in both CT and MRI technology have led to a decrease in ionizing radiation exposure and improved capabilities for evaluation of HCC, including, dynamic contrast-enhanced CT and MRI, perfusion CT and MRI, dual-energy CT, radiation dose reduction strategies, diffusion-weighted imaging, MR elastography, iron and fat quantification, and intravenous hepatobiliary contrast agents.
authors: Department of Radiology, Yale University School of Medicine, New Haven, CT 06520-8042, USA.
authors: Amir H
authors: AH
authors: Davarpanah
authors: Jeffrey C
authors: JC
authors: Weinreb
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000175:diagnosis*; D003952:Diagnostic Imaging / Q000639:trends; D005544:Forecasting; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis*; D008279:Magnetic Resonance Imaging / Q000379:methods; D014057:Tomography, X-Ray Computed